AU Patent

AU2017211737B2 — Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereof

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2022-04-28 · 4y expired

What this patent protects

The present invention provides a method for preparing a pharmaceutical composition comprising a quinoline derivative or a salt thereof. Specifically, the invention provides a method for preparing a pharmaceutical composition comprising an (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmetho…

USPTO Abstract

The present invention provides a method for preparing a pharmaceutical composition comprising a quinoline derivative or a salt thereof. Specifically, the invention provides a method for preparing a pharmaceutical composition comprising an (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)-propeneamide or a pharmaceutically acceptable salt thereof. The method comprises using a wetting agent comprising at least one organic solvent for a wet granulation in a preparation process of the pharmaceutical composition. The pharmaceutical composition prepared using the method has a uniform distribution of grain sizes during the preparation process and a property of rapid and uniform dissolution.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017211737B2
Jurisdiction
AU
Classification
Expires
2022-04-28
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.